CVS Takes Action on Cough Products With Phenylephrine Amid FDA Scrutiny

October 19, 2023

CVS Health has announced the removal of specific oral cough and cold products featuring phenylephrine as the sole active ingredient from its shelves. This decision comes after a panel of U.S. health regulators expressed reservations about the effectiveness of over-the-counter medicines containing phenylephrine, a common component in cold and cough syrups. While the U.S. Food and Drug Administration (FDA) has yet to remove phenylephrine from the list of approved ingredients for over-the-counter use, they plan to gather public opinions before reaching a decision.

Recent News

Bass Pro Shops CEO Focuses on Affordability Amid Inflation

In response to the persistent inflation affecting the economy, Johnny Morris, the founder and CEO of Bass Pro Shops, has reaffirmed the brand’s commitment to affordability. With inflation currently at 3.4%, above the Federal Reserve’s 2% target, Morris acknowledged the reality of rising costs and emphasized that the hunting, fishing, and outdoor sporting brand will maintain its focus on delivering value to its customers.

China is Spending $47.5 Billion For Chip Industry

China is significantly bolstering its semiconductor industry with a historic investment of $47.5 billion, reflecting its strategic push to become a global leader in advanced technology. This substantial fund comes as part of China’s broader ambition to achieve technological self-reliance amid escalating tensions with the United States over chip exports.